90/014,181MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY8,293,779Closed

Status

Reexamination Certificate Issued

Filed

Aug 8, 2018

Last Updated

Aug 30, 2019

Art Unit

3991

Requester

Unknown

Requested By

Third Party

Patent Owner

Nls-1 Pharma AG

P.O. Law Firm

Unknown

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (44 events)

Aug 31, 2019CCRDYApplication ready for PDX access by participating foreign offices
Aug 30, 2019REEXInput Issue Number and Issue Date for Reexamination
Aug 13, 2019RXPUBSReexam Forwarded to Office of Publications
Aug 12, 2019MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Aug 9, 2019MREXNRX - Mail Examiner Interview Summary Record
Aug 8, 2019PRXRParalegal Reexam Review Complete
Jul 19, 2019RXC/SRCertificate of Service
Jul 19, 2019RXAAF.Response to Final Filed (or Ready for Examiner Action)
Jul 3, 2019MRXFRRX - Mail Final Rejection
Jun 5, 2019IDSCInformation Disclosure Statement considered
May 31, 2019DOCKCase Docketed to Examiner in GAU
Apr 2, 2019RXA...Response after Non-Final Action
Apr 2, 2019RXIDS.Information Disclosure Statement Filed
Apr 2, 2019RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Apr 2, 2019RXC/SRCertificate of Service
Apr 2, 2019WIDSInformation Disclosure Statement (IDS) Filed
Mar 5, 2019RXLET.Miscellaneous Incoming Letter
Mar 5, 2019RXC/SRCertificate of Service
Feb 21, 2019MREXNRX - Mail Examiner Interview Summary Record
Feb 5, 2019MRXG.RX - Mail Extension of Time Period for Response Granted
Feb 4, 2019RXC/SRCertificate of Service
Feb 4, 2019RXRQ/TRequest for Extension of Time
Jan 10, 2019MR327RX - Mail Miscellaneous Communication to Applicant
Jan 4, 2019MR.NFRX - Mail Reexam Non-Final Action
Nov 29, 2018RXFWDXDate Forwarded to Examiner
Oct 16, 2018NRX.Notice of Reexam Published in Official Gazette
Sep 21, 2018MREXORX - Mail Ex Parte Request for Reexamination Granted
Sep 10, 2018IDSCInformation Disclosure Statement considered
Aug 27, 2018MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Aug 27, 2018RXLITSRReexam Litigation Search Conducted
Aug 23, 2018DOCKCase Docketed to Examiner in GAU
Aug 14, 2018MRXNReexamination Formalities Notice Mailed
Aug 14, 2018MRXNReexamination Formalities Notice Mailed
Aug 13, 2018RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Aug 13, 2018RXNREQAUNotice of assignment of reexamination request
Aug 13, 2018FTFIFITF set to NO - revise initial setting
Aug 13, 2018RXTTLRPTTitle Report
Aug 13, 2018RXNREQFDNotice of reexamination request filing date
Aug 8, 2018BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Aug 8, 2018RXOSUB.RReexamination requested by third party requester
Aug 8, 2018RXIDS.Information Disclosure Statement Filed
Aug 8, 2018WIDSInformation Disclosure Statement (IDS) Filed
Aug 8, 2018RXOSUBReceipt of Original Ex Parte Reexam Request
Aug 8, 2018RXC/SRCertificate of Service

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Oct 23, 2012
3.5-yr
Apr 23, 2016
7.5-yr
Apr 23, 2020
Paid Apr 14, 2020
11.5-yr
Apr 23, 2024
Paid Apr 10, 2024
Expiry
Feb 21, 2030

Entity Status

Small Entity

Expires

Feb 21, 2030 (3.9 yr remaining)

Term Adjustment

+499 days (~1.4 yr)

Assignments

20092010201120122013201420152016201720182019FiledERIC KONOFALL'ASSISTANCE PUBLIQUE-HOPITAUX DE PARISL'ASSISTANCE PUBLIQUE-HOPITAUX DE PARISASSISTANCE PUBLIQUE-HOPITAUX DE PARISNLS-1 PHARMA AGNLS-1 PHARMA AGNLS PHARMACEUTICS AG
AssignmentReel/Frame: 022221/0942Recorded: Feb 7, 2009

From

ERIC KONOFALInventor
Feb 2, 2009

To

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS

AssignmentReel/Frame: 041379/0310Recorded: Jan 17, 2017

From

L'ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Feb 10, 2016

To

NLS-1 PHARMA AG

AssignmentReel/Frame: 040906/0825Recorded: Nov 16, 2016

From

L'ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Feb 10, 2016

To

NLS-1 PHARMA AG

Name ChangeReel/Frame: 050352/0339Recorded: Sep 12, 2019

From

NLS-1 PHARMA AG
Jul 17, 2019

To

NLS PHARMACEUTICS AG